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P2X7 receptors belong to a family of ion channels1 Institute of Molecular Physiology
gated by extracellular ATP (Mackenzie et al., 1999).2 Section of Functional Genomics
P2X1–6 receptors are widely distributed in both neuronalUniversity of Sheffield
and nonneuronal cells, while P2X7 receptors are notSheffield S10 2TN
found in neurones but are highly expressed in immuneUnited Kingdom
and epithelial cells (Ralevic and Burnstock, 1998). A
unique feature of several of these ion channels is their
ability to change their ion selectivity during receptorSummary
activation (Surprenant et al., 1996; Virginio et al., 1999a;
Khakh et al., 1999). The channel that opens initially (i.e.,The proinflammatory cytokine interleukin-1 (IL-1) is
within several milliseconds) is permeable only to smalla secreted protein that lacks a signal peptide and does
cations, including calcium; however, if the ATP applica-not follow currently known pathways of secretion. Its
tion is prolonged for 10–30 s, some P2X receptors (P2X2,efficient release from activated immune cells requires
P2X4, P2X2/3, and P2X7) become permeable to larger cat-a secondary stimulus such as extracellular ATP acting
ions up to approximately 600–900 Da. Although the mo-on P2X7 receptors. We show that human THP-1 mono-
lecular and cellular mechanisms underlying this porecytes shed microvesicles from their plasma membrane
dilatation are unknown, pore dilatation per se cannotwithin 2–5 s of activation of P2X7 receptors. Two min-
fully account for the even more dramatic morphologicalutes after such stimulation, the released microvesicles
changes that occur during and subsequent to activationcontained bioactive IL-1, which only later appeared
of P2X7 receptors but not the other P2X receptors. Thatin the vesicle-free supernatant. We conclude that mi-
is, activation of P2X7 receptors results in extensive cellcrovesicle shedding is a major secretory pathway for
membrane blebbing within seconds to minutes, and sus-rapid IL-1 release from activated monocytes and may
tained activation of the receptor for 30 min results inrepresent a more general mechanism for secretion of
eventual cell death 6–24 hr later as assayed by methodssimilar leaderless secretory proteins.
such as trypan blue uptake and release of lactate dehy-
drogenase (LDH) or chromium (Hogquist et al., 1991;Introduction
Ferrari et al., 1997; Sanz and DiVirgilio, 2000, Virginio et
al., 1999b). Prior to the recent biophysical demonstra-The cytokine IL-1 is the key initiator of the acute inflam-
tions that pore dilatation is the same at the P2X2 andmatory response (Dinarello, 1996), but the mechanism
P2X7 receptors (Virginio et al., 1999a, 1999b; Khakh etof its release from cells is enigmatic. This protein lacks
al., 1999; Khakh and Lester, 1999), it had been assumeda secretory signal sequence and does not follow the
that the cell death occurring after sustained P2X7 recep-classical endoplasmic reticulum-to-Golgi pathway of
tor activation was a direct result of pore dilatation re-secretion (Rubartelli and Sitia, 1997), nor is there any
sulting in eventual osmotic shock and cell lysis (Hog-indication that it is stored in or released from exocytotic
quist et al., 1991; DiVirgilio et al., 1998). Activation ofgranules, although a small fraction of this cytokine has
P2X2 receptors expressed in HEK cells or present inbeen found in secreted endolysosomes (Andrei et al.,
sensory or autonomic neurones, however, never results
1999). It is synthesized in immune cells of monocytic
in membrane blebbing and/or subsequent cell death,
origin as a biologically inactive 31 kDa precursor mole-
even during application of ATP for several hours (Virginio
cule that is cleaved to its active 17 kDa form by IL-1- et al., 1999b; Khakh et al., 1999; Khakh and Lester, 1999).
converting enzyme (ICE or caspase-1) (Dinarello, 1996; These results call into question previous suggestions
Zeuner et al., 1999). Cleavage of proIL-1 is tightly cou- that IL-1 release evoked by activation of P2X7 receptorspled to its release because processed IL-1 can only be may be due to apoptotic and/or necrotic cell death via
detected extracellularly (Dinarello, 1996; Hogquist et al., pore dilatation sequelae.
1991). An initial inflammatory stimulus such as bacterial Many studies have concluded that it is the P2X7 recep-
endotoxin initiates synthesis of both pro-caspase-1 and tor that is responsible for the ATP-mediated IL-1 release
pro-IL-1 (i.e., the caspase cascade), but in the absence from activated monocytes, macrophage, and microglia
of a secondary stimulus, processing and release of IL-1 (DiVirgilio et al., 1998); this has now been confirmed by
are inefficient, with most of the newly synthesized prod- results from transgenic mice lacking the P2X7 receptor
ucts remaining intracellular and unprocessed or being where monocytes primed with the bacterial endotoxin
degraded (Hogquist et al., 1991; Perregaux and Gabel, lipopolysaccharide no longer release IL-1 in response
1994; Ferrari et al., 1997; Sanz and Di Virglio, 2000, Di to application of ATP nor do these cells die during pro-
Virgilio et al., 1998). The only known physiological stimuli longed ATP application (Solle et al., 2001). This apparent
for the processing and immediate release of bioactive correlation between P2X7 receptor-mediated IL-1 re-
IL-1 are cytotoxic T cells and extracellular ATP acting lease and cell death appears to support the concept that
ATP-mediated aponecrosis may indeed be responsible
for release of IL-1whether or not the underlying mecha-3Correspondence: a.surprenant@sheffield.ac.uk
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nism involves pore dilatation. However, previous studies normal extracellular solution (Figure 1B). However,
within 30–90 s of applying BzATP to HEK cells, thehave measured IL-1 release and cell death criteria only
after prolonged (30 min) P2X7 receptor activation. Be- plasma membrane exhibited extensive bleb formation
(Figures 1A and 1C; see Supplemental Movie S1 atcause membrane blebbing is a commonly accepted ex-
tranuclear marker of a cell undergoing apoptosis and/ http://www.immunity.com/cgi/content/full/15/5/825/
DC1). THP-1 cells showed a much more variable timeor necrosis (Wyllie et al., 1980; Majno and Joris, 1995)
and because significant membrane blebbing occurs in to onset of initial membrane blebbing, from 90–480 s in
LPS-primed cells and 90–500 s in nonprimed cells. Thethe first few minutes of P2X7 receptor activation, the
original aim of the present study was to determine appearance of blebs was not associated with any loss
of membrane seal during patch clamp recordings for upwhether this apparently rapid aponecrosis might be as-
sociated with a similarly rapid release of IL-1 from to 2 hr subsequently (n  5 HEK cells and 8 THP-1
monocytes) and was not due to osmotic shock becauseactivated monocytes.
Toward this aim, we examined HEK cells heterolo- it was not prevented by hypertonic solutions (400–600
mOsm, n  4).gously expressing the P2X7 receptor and human mono-
cyte THP-1 cells; these are known to initiate the caspase Biochemical Measurements
During continuous application of BzATP, the dye BCECFcascade and release bioactive IL-1 in response to P2X7
receptor activation after lipopolysaccharide priming (520 Da) was retained in the cell, trypan blue was ex-
cluded from HEK cells for up to 40 min and more than(Humphreys and Dubyak, 1998; Grahames et al., 1999).
To our surprise, we found that bioactive IL-1 was re- 4 hr from THP-1 cells, and no LDH was detected in
medium collected from HEK or THP-1 cells exposed toleased within the first 2 min of P2X7 receptor activation
with no concomitant cell death. This cytokine was con- BzATP for 5, 10, or 30 min (n  3). A previous study has
also shown that LDH is not released from LPS-treatedtained within microvesicles (0.5 m diameter) that
were shed from the plasma membrane within seconds and nontreated THP-1 cells during 4 hr of continuous
BzATP application (Grahames et al., 1999).of P2X7 receptor activation. Rapid plasma membrane
shedding of microvesicles containing IL-1 has not been Annexin-V Binding Assay for Apoptosis
Annexin-V is a high-affinity phosphatidylserine (PS)demonstrated previously and represents a new secre-
tory pathway that may possibly underlie release of simi- binding protein which is widely used as a marker of cells
destined for, or in the execution phase of, cell death bylar leaderless secretory proteins.
apoptosis because translocation of PS from the inner
leaflet of the plasma membrane to the outer (PS flip) is
a general feature of such apoptotic cells (Majno and Joris,Results
1995). We applied fluorescein-conjugated annexin-V to
HEK cells prior to and at 2, 10, and 30 min of P2X7No Cell Death Occurs During Initial 30 Min
of Sustained P2X7 Receptor Activation receptor activation with BzATP (100M); prior to agonist
application 2% of cells were annexin-positive whileBecause of the widely held view that IL-1 is liberated as
a consequence of cell death, we used several different 95% of cells were annexin-positive at all three of the
time points examined (Figure 2). However, there wasapproaches to assess this within the first 30 min after
applying extracellular ATP or the related agonist ben- no subsequent loss of cells over 24 hr after the 2 min
application of BzATP and PS flip completely reversedzoyl-(4-benzoyl)-ATP (BzATP).
Biophysical Measurements within 3 hr (Figure 2A). A similar reversal of the PS trans-
location without subsequent cell death was observedWe made whole-cell recordings from HEK cells (n  51)
expressing the P2X7 receptor (Surprenant et al., 1996) when P2X7 receptor activation was limited to 10 min
(data not shown). In contrast, prolonged BzATP applica-and from human THP-1 monocytes which had (n  14)
or had not (n  21) been exposed to lipopolysaccharide tion (30 min) resulted in irreversible PS flip and virtual
loss of all cells within 6 hr (Figure 2B).(LPS). The kinetics of P2X7-evoked currents recorded
from HEK cells during very brief (1–30 s) applications of In brief, these experiments show that application of
BzATP for up to 10 min results in an inward cation cur-ATP or BzATP have been described in detail previously
(Surprenant et al., 1996; Virginio et al., 1999b; Hibell et rent, extensive membrane blebbing, and PS flip, but it
did not lead to cell death.al., 2000). In THP-1 monocytes, the peak amplitude of
the current evoked by BzATP (300 M) varied greatly in
cells that had not been exposed to LPS (40–2100 pA, Rapid Plasma Membrane Vesicle Shedding Occurs
mean  500  131 pA) but not in LPS-primed cells within Seconds of P2X7 Receptor Stimulation
(1300–2360 pA, mean 1800  88 pA), with no significant Capacitance Measurements
change in surface area as measured by membrane ca- Membrane capacitance recorded after a 2 min applica-
pacitance (37  3 pF versus 35  4 pF) or obvious tion of BzATP was decreased by 22%  2% in HEK
differences in overall cell morphology. The significant cells (range 6%–46%, n  28) and by 34%  6% (range
increase in BzATP-evoked currents in LPS-primed 3%–46%, n  8) in THP-1 monocytes (Figure 3A). The
monocytes is most likely due to increased P2X7 receptor drop in cell capacitance did not progress significantly
expression in view of previous work that showed signifi- after the initial 2–5 min of agonist application (Figure
cant increases in P2X7 mRNA levels in these cells after 3B); neither did it recover in 30–45 min subsequent to
LPS treatment (Humphreys and Dubyak, 1998). Prolonged agonist application (n  6). The decrease in membrane
application of BzATP for 1–10 min elicited a sustained capacitance was blocked by removal of extracellular
calcium (Figure 3A) even though membrane blebbinginward cationic current which was readily reversible in
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Figure 1. Activation of P2X7 Receptors
Causes Membrane Blebbing but Not Cell Lysis
(A) Scanning electron microscopic photos of
HEK cells expressing rat P2X7 receptor; con-
trol cell shows typical morphology with rough
surface and both fine filopodia and sheet-like
lamellipodia while cell exposed to BzATP for
2 min shows smooth surface and numerous
large (1 m) blebs and small (0.5 m) mi-
crovesicles.
(B) The membrane current recorded from
HEK cell during very brief (3 s, at filled circles)
and sustained (90 s, at gray bar) application
of BzATP; note that the current quickly re-
turns to baseline after prolonged BzATP even
though extensive membrane blebbing (C) oc-
curs after about 70 s of receptor activation.
was not. However, it was still observed in the absence ding of NBD-labeled vesicles was never observed in
nontransfected or P2X2 receptor-transfected HEK cellsof extracellular sodium (capacitance decrease after 5
min BzATP was 31%  5% and 39%  8% in HEK and during application of BzATP (200 M) or ATP (100 M;
see Supplemental Movie S4).THP-1 cells, respectively; n  4), which prevented the
early formation of blebs (Virginio et al., 1999a). No signifi-
cant change in membrane capacitance occurred in time- PS Flip Precedes Vesicle Shedding and PS Is Exposed
on Shed Microvesiclescontrol recordings from unstimulated HEK cells nor in
P2X2-transfected HEK cells exposed to ATP (100 M) We next examined the kinetics of the reversible PS flip
we had observed after brief 2–10 min exposure to BzATPfor up to 10 min (Figure 3A), nor did these cells exhibit
ATP-evoked blebbing. These experiments indicate a (Figure 2) in order to determine whether it was associ-
ated with the rapid microvesicle shedding. Using thesignificant loss in membrane surface area following a 2
min activation of the P2X7 receptor and suggest that fluorescein-conjugated annexin-V and video imaging,
we detected exposure of PS on the outer leaflet of thethis is unrelated to the formation of membrane blebs.
Microscopy plasma membrane as early as 1–2 s after application of
BzATP. The microvesicles that were subsequently shedThis irreversible loss of plasma membrane and the ob-
servation of microvesicles (0.5 m diameter) under were labeled with annexin (Figure 5A, see Supplemental
Movie S5), thus showing that PS was also exposed onscanning electron microscopy (Figure 1A) suggested a
shedding of microvesicles which would be below the their outer membrane. We were not able to determine
whether the PS flip was dependent on extracellular cal-resolution of standard bright-field microscopy (e.g., see
Supplemental Movie S1 at http://www.immunity.com/ cium because annexin-V binds specifically to PS only
in the presence of calcium (Wiedmer et al., 1990; Andreecgi/content/full/15/5/825/DC1). By fluorescence video
microscopy and nitrobenzoxadiazole (NBD)-conjugated et al., 1990). FM1-43, which has been used to assess
PS translocation in the absence of calcium (Zweifach,lipid to label the plasma membrane (Chattopadhyay,
1990), we clearly observed shedding of microvesicles 2000) rapidly entered the cell through the large pore
induced by BzATP resulting in fluorescence of intracellu-within 4–20 s of applying BzATP (Figure 4). The distinc-
tive pinching off of these microvesicles from the plasma lar organelles and the cell nucleus (data not shown).
This result is not unexpected in view of its similarity in sizemembrane is readily visualized in Supplemental Movies
S2 and S3, which are typical examples recorded from and charge to other fluorescent dyes such as YO-PRO-1
which are commonly used to assess pore formation inTHP-1 monocytes (n  54) and HEK cells (n  42),
respectively. Like the decrease in membrane capaci- cells expressing P2X7 receptors (Mackenzie et al., 1999;
Virginio et al., 1999b; Hibell et al., 2000).tance, microvesicle shedding also required extracellular
calcium (n  30 HEK and 24 THP1 cells; Figures 4B A comparison of the relative times to onset of annexin
binding, NBD-labeled membrane vesicle shedding, andand 4C). Microvesicle shedding from LPS-primed and
nonprimed THP-1 cells was qualitatively similar. Shed- membrane blebbing shows that annexin binding pre-
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Figure 3. Activation of P2X7 Receptors Causes Loss of Plasma
Membrane
(A) The change in membrane capacitance in HEK cells (black) and
THP-1 monocytes (gray) after a 2 min exposure to BzATP; the num-
bers below each bar are numbers of cells.
(B) The decrease in membrane capacitance plateaus with increasing
duration of receptor activation. The graph plots membrane capaci-
tance as a function of time of BzATP application in HEK cells (filled
circles) or monocytes (open circles); each application of BzATP was
followed by a 5–7 min wash. Except for the 10 min time points (seeFigure 2. PS Flip Is Reversible and Not Associated with Cell Death
text), n 4–7 for each point. The lines are best-fit single exponentialafter Brief, but Not Prolonged, Receptor Stimulation
functions with time constants of 1.1 min (HEK) and 0.7 min (THP1),
HEK cells were exposed to BzATP for (A) 2 min or (B) 30 min; FITC-
respectively.
conjugated annexin (5 l/100 l solution) was applied 0, 1, 3, 6, or
24 hr later, and annexin-positive cells (circles; expressed as percent
of total) and total number of cells (squares; expressed as percent ments were normalized to the amount of IL-1measured
of time-matched controls) were counted (n 3 for each time point).
at the 30 min time point, IL-1 was significantly greaterNo 24 hr time point for annexin binding is shown in (B) because no
in the microvesicle-containing than in the microvesicle-cells were present.
free fraction for all times points 30 min (Figure 6B).
Significant levels of IL-1 were only detected in the
microvesicle fraction after triton treatment to releasecedes vesicle shedding by 2–10 s while membrane bleb-
bing does not occur until some 40 s (in HEK cells) to vesicle contents; no IL-1 (12% of background, n 
3) was detected in this fraction in the absence of triton,150 s (in monocytes) later (Figure 5B).
thus demonstrating that the cytokine was contained
within the microvesicles. Moreover, there was no signifi-Shed Microvesicles Contain IL-1
We asked whether IL-1 was present in microvesicles cant difference in IL-1 content for microvesicles that
were incubated with high concentrations of trypsin (n shed from activated THP-1 monocytes by isolating mi-
crovesicles released into the supernatant with annexin- 4), showing that the initially released IL-1 was insensi-
tive to protease digestion and further adding to the con-coated beads and then assaying for the presence of IL-1
in both vesicular and vesicle-free supernatant fractions. clusion that the cytokine was intravesicular.
We considered the possibility that the IL-1 that weIL-1 was detected in the microvesicles at the earliest
time point (1–2 min, n  6/7 experiments) after P2X7 measured was due to lysis of a small subset of cells
either by the BzATP or LPS stimuli or by triton treatmentreceptor activation and increased in an approximately
exponential manner with a time constant of 5.6  1 of cells present in the collected medium. We discounted
this because no trypan blue-positive cells were ob-min (n  6, Figure 6A). This plateau in the release of
microvesicles is similar to our results with decreases in served immediately after collecting the medium and mi-
croscopic inspection of the total medium collected priormembrane capacitance that also reached a steady value
after 2–5 min of continuous receptor activation and sug- to separation into vesicle and vesicle-free fractions
showed at most one cell, irrespective of duration orgests the possibility of a readily releasable pool of mi-
crovesicles. Secretion experiments showed that, while presence of BzATP or LPS. Furthermore, the amount of
IL-1 measured in triton-treated supernatant (i.e., totalIL-1was consistently found in the microvesicle fraction
at all times points10 min, its presence in the microves- extracellular IL-1) at the 10 and 30 min time points was
12% and 28%, respectively of the total cellular contenticle-free fraction was quite variable for these shorter
times (Figure 6A). When data from all individual experi- (340 pg/105 cells versus 2900 pg/105 cells at 10 min and
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Figure 5. PS Flip Is Rapid and Precedes Microvesicle Shedding
(A) Fluorescent images of HEK cell during BzATP exposure (from
Frame 1, images at 5 s intervals are shown) in the presence of FITC-
conjugated annexin V. Annexin V (5 l/100 l solution) was present
for 2 min prior to BzATP without labeling the cell but labeling occurs
within 1 s of receptor activation, after which annexin-labeled mi-
crovesicle shedding is apparent (see Supplemental Movie S5).
(B) The graph shows a summary of all the experiments as illustrated
Figure 4. Rapid Microvesicle Shedding Following P2X7 Receptor in Supplemental Movies S1, S3, and S5. The time to onset (from the
Activation frame in which BzATP was added) for annexin binding to plasma
(A) Fluorescent images of two THP-1 monocytes labeled with NBD membrane, NBD-labeled particle shedding, and membrane bleb-
during exposure to BzATP; the frames are shown at 2 s intervals bing in HEK and THP-1 cells are indicated. Data are mean  SEM
from the time of BzATP application (Frame 1). Images have been of 5–12 cells.
shadowed with NIH Image 1.62 to accentuate the small vesicles
budding from the plasma membrane which can be seen clearly in
Supplemental Movie S2 (THP-1 monocyte) and Supplemental Movie was there measurable IL-1 in either fraction at 10 or
S3 (HEK cell). 30 min from LPS-treated cells in the absence of BzATP
(B) The kinetics of microvesicle release following P2X7 receptor stim- stimulation (n  2); these results are similar to thoseulation in HEK and THP-1 cells; individual fluorescent particles that
found in previous studies in which longer duration stimu-were 5 m distance from the plasma membrane were counted.
lation has been examined (Hogquist et al., 1991; Perre-
gaux and Gabel, 1994; Ferrari et al., 1997; Laliberte et
al., 1999; Grahames et al., 1999). IL-1 appeared in the520 pg/105 cells versus 1860 pg/105 cells at 30 min from
separate experiments). These values are similar to those microvesicle-free supernatant with a time lag of 2–10
min behind its presence in microvesicles (Figures 6A–obtained recently by Sanz and Di Virgilio (2000) who
found released IL-1 was 25% of cellular IL-1 content 6C). In the absence of extracellular calcium, no IL-1
was measured at 5 or 10 min and was reduced by 80%–after 30 min exposure to BzATP in similarly LPS-primed
microglia and conclusively ruled out any possibility that 90% at 30 min (Figure 6A).
Western blot analysis showed that microvesicularthe released IL-1was due to lysis of a small proportion
of cells or release of cytosolic contents. Moreover, no IL-1 consisted of both the unprocessed (31 kDa) and
the mature (17 kDa) form of this cytokine but any IL-1LDH could be detected after triton treatment of mi-
crovesicles or the microvesicle-free supernatant col- that may have been present in the microvesicle-free
supernatant (5 and 10 min time points) was below thelected 5 or 10 min after BzATP stimulation (n  2), thus
demonstrating that nonspecific cytosolic proteins are limits of immunoblot detection (n  3; Figure 6C). In
common with many previous reports (e.g., Hogquist etnot contained within these microvesicles. A similar result
was obtained in cells transfected with cytoplasmic GFP, al., 1991; Perregaux and Gabel, 1994; Laliberte et al.,
1999; Di Virgilio et al., 1998), we detected only the unpro-in that we observed no loss of fluorescence in GFP-
expressing HEK cells (n  35) or LPS-treated THP-1 cessed (31 kDa) but never the 17 kDa form of IL-1 in
cell extracts (Figure 6C). Our findings of the prominentcells (n  12) during exposure to BzATP for 2–10 min.
In THP-1 cells which had not been previously activated 17 kDa band also provide further confirmation that the
rapidly released IL-1 was not the result of cell lysis andwith LPS, BzATP application for up to 30 min did not
evoke measurable IL-1 release in either fraction, nor show that the bioactive form of the cytokine is present
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rescent protein (GFP) reporter assay. Stimulation of IL-1
receptors phosphorylates IRAK within 2 min, although
previous studies have only examined actions of rela-
tively high concentrations (10–200 ng/ml) of exogenous
IL-1 or IL-1 (Cao et al., 1996; Yamin and Miller, 1997;
Wesche et al., 1997; Li et al., 2000). We compared IRAK
immunoblots from HeLa cell extracts exposed for 5–8
min to medium obtained from LPS-treated THP-1 cells
exposed to BzATP for 10 min with those directly ex-
posed to 0.5 ng/ml recombinant IL-1, a concentration
our ELISA assays indicated was maximally present in the
released microvesicles at this time point (range 150–550
pg/ml, Figure 6A). Similar amounts of phosphorylated
IRAK were detected (Figure 6B). This result showed that
the shed microvesicles were capable of releasing their
contents onto other cells to activate IL-1 receptors and
that this release of contents from the microvesicles oc-
curred within at least 5 min. However, this method was
not sufficiently sensitive to determine whether microves-
icular contents released earlier were also capable of
downstream bioactivity. For these studies we used HeLa
cells which had been transfected with an EGFP-reporter
construct containing a cytokine-responsive promoter
which can detect activation of IL-1 receptors in HeLa
cells by concentrations of recombinant IL-1 as low as
2–5 pg/ml (Kiss-Toth et al., 2000). We counted green
cells after application of the total medium (microves
icles 	 supernatant) or microvesicle-free supernatant
(Figure 7; see Experimental Procedures). Only the me-
Figure 6. Bioactive IL-1 Is Present in Released Microvesicles dium containing microvesicles collected 2–10 min after
within 1 Min of P2X7 Receptor Activation and Precedes Release into BzATP application turned on GFP expression (Figures
Vesicle-Free Supernatant
7A and 7B). At the 30 min time point, there was activation
(A) Shown are two examples of results from individual secretion
of the target cells from both fractions, being consistentlyexperiments for IL-1 release; each point is the average  SEM of
greater from the total medium than from the microves-four replicate wells, each containing 2 
 105 cells; the results are
icle-free medium (Figure 7B). BzATP alone did not turnrepresentative of a further five similar experiments in normal solution
and three experiments in zero calcium. on GFP expression (Figure 7B), nor did medium col-
(B) The summary of all secretion experiments plotted as percent lected from untreated THP-1 cells (n  4), LPS-only
IL-1 relative to the amount at 30 min time point; n  7–9 for each cells, or cells exposed to BzATP but not LPS-primed
point.
(n  2 for each condition). IL-1 receptor antagonist(C) IL-1 immunoblot on SDS-PAGE gel from LPS-activated THP-1
(IL-1Ra, 20 M) blocked activation by the collected me-cells and medium exposed to BzATP for 10 min. Cell extract (lane
dium as well as the activation by IL-1 itself (Figure1) shows only a 31 kDa band; total medium (lane 2) obtained from
7.5 
 106 cells, concentrated through 10 kDa filter, shows both 7B). These results show that the IL-1 contained in the
forms of IL-1 as does fraction pulled-down with annexin beads released microvesicles at very early times can be re-
from medium obtained from a parallel set cells (lane 3). No bands leased onto other cells in physiologically significant
(lane 4) are detected from the annexin bead-depleted supernatant
amounts.obtained from the same experiment as lane 3.
(D) IRAK immunoblot of HeLa cells exposed to control medium
obtained from LPS-only treated THP-1 cells (lane 1) and medium Discussion
obtained from LPS-activated THP-1 cells exposed to BzATP for 10
min (lane 2) or treated with 0.5 ng/ml recombinant IL-1 (lane 3). Using fluorescent video microscopy and NBD-labeled
plasma membrane, we have shown that monocytes
shed microvesicles of 0.5 m diameter from their
in the rapidly released microvesicles at least as early plasma membrane within 2–5 s after activation of P2X7
as 5 min. receptors. Phosphatidylserine translocation (PS flip)
preceded microvesicle shedding as measured by FITC-
conjugated annexin-V binding to the plasma membrane.IL-1 in Shed Microvesicles Is Bioactive
We then asked whether the fully processed IL-1 within Microvesicle shedding was associated with a substan-
tial decrease in cell membrane area as measured bythe shed microvesicles could have any biological activity
at target cells expressing IL-1 receptors. We collected capacitance measurements; both phenomena were de-
pendent on extracellular calcium. PS flip after brief (10medium from activated or unactivated monocytes after
BzATP application, applied the medium to HeLa cells, min) receptor activation was reversible and was not as-
sociated with subsequent cell death for up to 24 hr.which express IL-1 receptors, and examined the effects
in two different bioassays, an interleukin-1 receptor- Using annexin-coated beads, we isolated microvesicles
released from LPS-primed monocytes during brief P2X7associated kinase (IRAK) immunoblot and a green fluo-
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Figure 7. IL-1 in Released Microvesicles Is
Bioactive
(A) Low-power fluorescent images of HeLa
cells expressing IL-8 promoter-EGFP re-
porter construct. Total medium (upper pan-
els) or microvesicle-free medium (lower pan-
els) collected at time points indicated from
experiments as in Figure 6 were applied to
cells for 6 hr to induce activation of the cyto-
kine-responsive promoter. Each image is 1
mm2 of a microwell in a 96 well plate; all wells
contained a confluent layer of cells by bright-
field observation.
(B) Positive cells/well plotted as a function of
the time after BzATP application onto THP-1
cells, at which point the medium was col-
lected and placed onto the HeLa cells.
(C) Summary of results from IL8-EGFP re-
porter assay when IL-1 itself, the collected
medium in the absence or presence of IL-1
receptor antagonist (20 M), or BzATP alone
(200 M) was applied. The numbers in paren-
theses indicate the number of experiments.
The data from medium are from a separate
series of experiments from those plotted in (B).
receptor activation and measured IL-1 content; within shedding of plasma membrane particles, which are
known as microvesicles, the term we have used (Heijnen2 min IL-1 was present in the isolated microvesicles
and only later appeared in the vesicle-free supernatant. et al., 1999; Aupeix et al., 1997). Microvesicles have
ubiquitously been associated with PS exposure whileThe IL-1 in the microvesicles was bioactive, as assayed
by its ability to stimulate IRAK phosphorylation in HeLa exosomes have not (Heijnen et al., 1999; Aupeix et al.,
1997; Satta et al., 1994; Zwaal and Schroit, 1997; Da-cells and transcription in HeLa cells expressing an
IL8-GFP reporter gene. Because we observed the 17 chary-Prigent et al., 1993). The decreased membrane
capacitance associated with P2X7 receptor activationkDa form of IL-1 in the microvesicular fraction on West-
ern blots and because only the 17 kDa form of IL-1 is abnegates the possibility that the PS-flipped IL-1-
containing vesicles we isolated resulted from exocytosisbioactive, we can safely assume the IL-1 released from
these shed microvesicles is the mature 17 kDa molecule. of exosomes, the mechanism that has previously been
suggested to be responsible for a portion of IL-1 releaseWe can therefore conclude that shedding of plasma
membrane microvesicles containing fully processed after combined and prolonged LPS and ATP stimulation
(Andrei et al., 1999). Our data provide direct (membraneIL-1 is the major secretory pathway for rapid release
of this cytokine. It should be emphasized that our experi- capacitance) and indirect (annexin-V and NBD imaging)
evidence that the source of the IL-1-containing mi-ments do not rule out the possibility that other cytokines
may be released along with IL-1; in particular we might crovesicles released upon P2X7 receptor activation is,
indeed, the plasma membrane.expect IL-1 to be secreted in this manner. However,
the finding that the IL-1 receptor antagonist, which is No previous studies of cytokine-secreting cells have
measured microvesicle shedding or IL-1 release overselective for IL-1 ( and  forms) but does not block
actions of other known cytokines (Dinarello, 1996), com- the rapid time course we have examined, although mi-
crovesicle shedding is certainly a common occurrencepletely blocked activation of HeLa cells exposed to mi-
crovesicles released from THP-1 cells (e.g., Figure 7) in hematopoietic and other immune cells. Earlier workers
have isolated biochemically (Satta et al., 1994; Zwaalmeans that this bioactivity we observed is due solely to
activation of IL-1 receptors by released bioactive IL-1. and Schroit, 1997; Dachary-Pringet et al., 1993; Marti-
nez-Lorenzo et al., 1999) or observed by electron mi-Two types of membrane vesicles released into the
extracellular space have been demonstrated in previous croscopy (Denzer et al., 2000) membrane microvesicles
of 0.1–0.4 m diameter in the supernatant of monocytesstudies on platelets, T cells, and/or monocytes as a result
of various stimuli: exosomes derived from exocytosis of after several hours of LPS stimulation (Satta et al., 1994)
or T cells after as short as 15 min stimulation with anti-endolysosome-related multivesicular bodies, and the
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CD3 or PHA (Martinez-Lorenzo et al., 1999). These mi- cells, but our results and another recent study (Hammill
crovesicles could be labeled with annexin-V, were found et al., 1999) show that this is not a reliable marker of
to possess a number of MHC class II proteins, integrin cells destined for cell death. Instead, it may, in some
molecules such as P selectin and Fas ligand, and were circumstances, indicate a cell engaged in membrane
greatly increased after treatment with the calcium iono- shedding of secretory proteins.
phore, A23187, although they were not assayed for pres- How the released microvesicles ultimately release
ence of cytokines (Satta et al., 1994; Zwaal and Schroit, IL-1 onto interleukin receptors of other cells remains
1997; Dachary-Pringent et al., 1993; Denzer et al., 2000; for future studies. It may be difficult to approach this
Gu et al., 1998; Martinez-Lorenzo et al., 1999). In these by studies on monocytes in tissue culture conditions,
previous studies, microvesicles were isolated by ultra- where release occurs into a virtually infinite solution, or
centrifugation, which would have expelled any vesicular in vivo, especially at sites of inflammation, where the
contents such as IL-1, since we found all but the most dissemination of microvesicles may be highly restricted.
gentle centrifugation of the microvesicles we isolated In the present study, IL-1 in the microvesicular fraction
resulted in loss of IL-1 from the vesicular fraction. In reached a plateau after 10–20 min, while that in the
common with results from several previous studies vesicle-free supernatant continued to increase over the
(Hogquist et al., 1991; Perregaux and Gabel, 1994; Fer- 30 min time period examined. This could indicate dis-
rari et al., 1997; Sanz and Di Vrigilio 2000, Laliberte et tinct release processes, one from a “readily releasable”
al., 1999; Grahames et al., 1999), we observed that IL-1 pool of microvesicles and another from endolysosomes
release was minimal or undetectable after LPS stimula- (Andrei et al., 1999) or an as-yet-unidentified mecha-
tion alone and after BzATP stimulation alone. We found nism, or it could simply be due to microvesicle disruption
IL-1 in microvesicles within 1 min of receptor activation during time in the extracellular solution. The clear con-
in LPS-primed monocytes and the fully processed 17 clusion that we can make from our IL-1ELISA measure-
kDa molecule was detected within 5 min of P2X7 recep- ments and IL8-GFP reporter bioassay results is that
tor activation. A23187 does not cause release of bio- bioactive IL-1 is present in released microvesicles at
active 17 kDa IL-1 from LPS-primed macrophage least as early as 2 min after P2X7 receptor activation
(Perregaux et al., 1992; Bahl and Foreman, 1994). (e.g., Figures 6 and 7). Such rapid release of this key
Nevertheless, the process of rapid microvesicle shed- initiator of the acute inflammatory response has not
ding required only activation of P2X7 receptors and ex- been appreciated previously, although recent in vivo
tracellular calcium whether or not the vesicles contained experiments have commented on the unexpectedly
IL-1 (i.e., it occurred in HEK cells as well as in non- rapid release of IL-1 in neurotrauma (Fassbender et
LPS-treated THP-1 cells). Thus, it seems likely that the al., 2000). Can we reconcile our new findings of rapid
antigen-presenting microvesicles isolated in previous IL-1 release without subsequent cell death with previ-
studies are the same as the microvesicles isolated in ous findings of cell death, release of endolysosomes,
our study but only when P2X7 receptors are engaged and IL-1 release when receptor activation is pro-
do these microvesicles contain processed IL-1. It re- longed? One may speculate that these events represent
mains to be determined whether, indeed, these are the two ends of a continuum based on similar underlying
same population of microvesicles, and/or what other mechanism(s). These events may involve time-depen-
molecules are expressed on the surface of, and con- dent recruitment of distinct associated proteins (Schil-
tained within, the rapidly shed microvesicles we have ling et al., 1999), pore dilatation (Virginio et al. 1999a,
now identified and shown to contain bioactive IL-1. 1999b), or other second messenger pathways (Di Virgilio
However, the fact that these microvesicles are associ- et al., 1998).
ated with PS exposure provides the means for their In summary, our data suggest the following sequence
specific targeting to PS receptor-expressing cells in a of events. Following priming of the cytokine-caspase
manner similar to that well known for platelet aggrega-
cascade by the initial inflammatory stimulus, activation
tion and procoagulant activity (Zwaal and Schroit, 1997;
of P2X7 receptors by extracellular ATP causes PS flipAllen et al., 1988). Dendritic cells in particular express
and loss of plasma membrane asymmetry within a fewthe PS receptor (Fadok et al., 1992, 2000), and IL-1
seconds. Some seconds later, PS-exposed microves-stimulation of dendritic cells is the first step toward
icles containing bioactive IL-1 pinch off from the cell,initiation of the acute inflammatory response (Hart,
and this IL-1 is able to activate IL-1 receptors on other1997); thus, these rapidly released PS-flipped microves-
cells. The rapidity of the IL-1 release is appropriate toicles may be targeted specifically for dendritic cells.
its role as the initial player in the inflammatory cytokineRelease of mature (17 kDa) bioactive IL-1 evoked by
cascade, but it might also indicate signaling roles inP2X7 receptor activation in LPS-stimulated monocytes
processes other than inflammation. In a broader sense,and microglia has been suggested to result from an
the results suggest that the microvesicle formations andactive process involved with apoptosis and subsequent
release might be a more general pathway for the secre-death of the releasing cell (see Di Virgilio et al., 1998).
tion of cytoplasmic secretory proteins that lack leaderAlthough it is likely that much of the IL-1 released after
sequences.prolonged stimulation of P2X7 receptors may be from
microvesicles shed from late apoptotic cells, we found
Experimental Proceduresno evidence for apoptosis, necrosis, cell lysis, or mem-
brane breakdown in cells exposed to BzATP for up to Cells and Reagents
10 min. Indeed, PS flip was reversible within 3 hr after HEK293 cells stably expressing the rat P2X7 receptor have been
these brief BzATP applications. PS flip has been a com- described (Virginio et al., 1999a). Human THP-1 monocytes were
differentiated with 0.5 M phorbol-12-myristate 13-acetate (PMA)monly accepted hallmark of early events of apoptotic
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for 3 hr and then plated onto coverslips for single-cell experiments protocol yielded significantly greater values for IL-1 content in the
vesicular fraction than the bead-free supernatant, suggesting thatand into 24 well plates or 35 mm petris for IL-1 release experiments
(Grahames et al., 1999). Transient transfection with GFP was per- even this gentle spin was sufficient to cause some release of vesicu-
lar contents. Fractions containing the beads were treated with 2%formed by using lipofectin as previously described (Virginio et al.
1999a); transfection yielded GFP-positive cells in 80% of HEK Triton X to release vesicle contents prior to ELISA. Because annexin
V binds to PS only in the presence of calcium (Andree et al., 1990),cells and 2% of THP-1 monocytes. Biotin and FITC-conjugated
annexin-V, 2-6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) hexanoyl-1-hex- release experiments in zero calcium solution were analyzed by treat-
ing the total medium (microvesicles 	 supernatant) with 2% Tritonadecanoyl-sn-glycero-3-phosphocholine (NBD) and 2,7-bis-(car-
boxyethyl)-5-(6)-carboxyfluorescein (BCECF-AM) were obtained X and then assaying for IL-1 levels. Vesicular and vesicle-free
supernatant fractions were assayed for IL-1 using the ENDOGENfrom Molecular Probes. Streptavidin-agarose beads, 3-O-(4-benzo-
yl)benzoyl-ATP (BzATP) and lipopolysaccharide (LPS) were from human IL-1ELISA kit or with the R&D Systems human IL-1Quanti-
Glo ELISA kit. Supernatant or triton-lysed cells or microvesiclesSigma; recombinant human IL-1 was from Endogen. A concentra-
tion of BzATP producing approximately 90% of maximum response were assayed for LDH content by using the CytoTox 96 assay kit
(Promega). In some experiments, medium was collected from LPS-(EC90) was used in all experiments described herein; this was 30 or
100 M for HEK293 cells heterologously expressing P2X7 receptors treated THP-1 cells after stimulation with BzATP for 15 min and
incubated with supramaximal concentrations of trypsin (1 g/105and 200 or 300 M for THP-1 monocytes (Mackenzie et al., 1999;
Surprenant et al., 1996; Hibell et al., 2000; Grahames et al., 1999). cells) at 37C for 15–40 min, after which microvesicle fraction was
collected by the annexin bead pulldown and assayed for IL-1.
Exogenous recombinant IL-1 (1.5–3 ng) was completely digestedMicroscopy and Electrophysiology
by a lower amount of trypsin (100 ng) within 15 min, as assayed byStandard whole-cell recordings and digital video microscopy using
Western blotting; this served as the control for the protease digesta Zeiss Axiovert 100 with Fluar X20, X40, or X100 objective, HEKA
experiments.EPC9 with Pulse software, and the Photonics monochromator
(TILLion VISION) system were as described previously (Virginio et
al., 1999a, 1999b). Extracellular solution contained (in mM): NaCl Immunoblots
Supernatants from LPS-treated THP-1 monocytes (7.5 
 106 cells)147 or NMDG 147, KCl 2, MgCl2 1, CaCl2 (2 or 0 with EGTA), Hepes
10, glucose 12; intracellular solution (mM) was: NaCl 147, Hepes were withdrawn following activation for 5 or 10 min with 300 M
BzATP and were either passed through annexin-coated beads as10, EGTA 10 (pH 7.3, osmolarity 300 mOsm). Hypertonic solution
contained 270 mM sucrose. We were unable to track membrane used for ELISAs or immediately concentrated using 10 kDa nominal
molecular weight cutoff filters (Flowgen) and then lysed in SDS-capacitance during P2X7 receptor activation using currently avail-
able methods (Lollike and Lindau, 1999) because of the massive PAGE loading buffer containing protease inhibitors (Cocktail III, Cal-
biochem). THP-1 cell extracts were prepared by lysis in PBS 	 1%increase in conductance (from resting value of approximately 50 pS
to 100 nS in HEK cells and from about 100 pS to 10–60 nS in NP40 with protease inhibitors, followed by centrifugation to remove
particulate material. Protein bound to the annexin-coated beadsTHP-1 cells); therefore, we recorded membrane capacitance values
15 min after establishment of whole-cell recording prior to any stimu- was eluted by the addition of SDS-PAGE loading buffer and heating
to 95C. Cell extracts and concentrated supernatants were analyzedlation and 1 min after cessation of BzATP application. NBD labeling
of plasma membrane was achieved by incubation with 5–10 M for on a 12% polyacrylamide gel and transferred onto PVDF membrane.
IL-1 was detected by using a polyclonal human anti-IL-1 Ab2–5 min at room temperature; fluorescent imaging was carried out
in the subsequent 5–10 min. NIH Image 1.62 software was used to (Santa Cruz Biotech, sc-7884). IRAK assay was the same as de-
scribed in detail previously (Yamin and Miller, 1997; Li et al., 2000).make Quicktime movies from digital images captured at 0.2–2 Hz;
all movies show 1–4 frames prior to agonist application and the Briefly, supernatants from 6 
 106 THP-1 cells were withdrawn fol-
lowing activation for 10 min with 300 M BzATP and immediatelysubsequent 2 min. Measurements of NBD-labeled microvesicle
shedding and annexin binding were made in a nonperfused bath added to 5
 106 HeLa cells for 5–8 min, in the presence of inhibitors
of proteasome activity (Peptides International, Louisville, KY). Ex-for better resolution of released vesicles, but because of this and
because images were recorded in a single focal plane, it is not tracts were harvested immediately by scraping cells in lysis buffer
and solubilized for 2 hr at 4C. IRAK was immunoprecipitated usingpossible to obtain an accurate count of the total number released
from one cell nor to make interpretations concerning subsequent 5 l of polyclonal anti-IRAK Ab (Upstate Biotech, Lake Placid, NY)
by overnight incubation, followed by addition of protein G sepharosemovements of these particles. We have counted as microvesicles
only those fluorescent particles that unequivocally moved from the (Amersham Phramacia Biotech) for 2 hr. Samples were spun and
washed four times in lysis buffer. Bound protein was eluted in 40membrane edge to 5 m away from cell or out of the field of view
and have ignored any fluorescent movements that appears to remain l SDS-PAGE loading buffer by heating to 95C. Extracts were ana-
lyzed on a 10% polyacrylamide gel and transferred onto PVDF mem-attached to any part of the cell. For scanning electron microscopy,
cells were processed as described previously (Hallam and Rink, brane, and IRAK was detected with IRAK Ab.
1985) and viewed with a Philips XL 30 FEG scanning electron micro-
scope. Green Fluorescent Protein (GFP) Reporter Assay
Methods have been described in detail previously (Kiss-Toth et
al., 2000). Briefly, the human IL8 promoter was subcloned into theIL-1 and LDH Release
PMA-differentiated THP-1 cells (2 
 105 cells/well in 24 well plate) pd2EGFP1 vector (Clontech) to yield pIL8/d2EGFP1. This cDNA (0.5
g/well) was used to transfect 90% confluent layers of HeLa cells,were treated for 2 or 6 hr with the endotoxin LPS (10 g/ml). Cells
were washed twice with extracellular solution, and BzATP (200 or plated into 96 well plates with SuperFect (Qiagen); control wells
were similarly transfected with pEGFP1 vector. Twenty-four hours300 M) was applied for time periods between 1–30 min. Superna-
tant was collected and gently mixed for 10–30 min with biotin- after transfection, each well was viewed with a 10
 fluorescence
objective to count background green cells; no well transfected withannexin-coated streptavidin-agarose beads. Preliminary experi-
ments using the 30 min time point were conducted to determine pIL8/d2EGFP1 had 4 green cells (n  225 wells from 5 separate
transfections), while pEGFP1-transfected wells had 2650  256saturating concentrations of annexin to ensure complete pull-down
of PS-exposed microvesicles; this was 20 l annexin/20 l beads/ green cells (n 20 wells from 5 transfections). Culture medium was
then removed and test medium (100 l) was added; cells were150 l sample. We also compared IL-1 from supernatants exposed
to beads only with those from annexin-coated beads; ELISA assays incubated at 37C for a further 6 hr, at which time green cells were
again counted. Examination of wells under bright field at this timeshowed IL-1 from beads-only fraction was 0%–10% of IL-1 ob-
tained from annexin-coated beads fraction (n 2, 10 min time point). revealed that cells in all wells remained confluent; therefore we
assumed total cells/well were the same and did not change duringThese results confirmed that annexin was required for effective pull-
down of IL-1-containing microvesicles. Beads were separated from incubation with test medium. We were not able to carry out this
assay using the isolated microvesicles alone because the annexin-supernatant by gentle spin (1200 rpm/3 min) in initial experiments
or by allowing to settle for 30 min in later experiments; the latter coated beads, at the concentration used for our pull-down assay,
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caused disadherence of the HeLa cells and obscured visibility; IL-1beta release by activating the purinergic P2Z receptor of human
macrophages. J. Immunol. 159, 1451–1458.therefore, we compared effects of total medium with vesicle-free
medium. Images (512 
 512 pixels) were obtained using the 10
 Gardella, S., Andre, C., Costigliolo, S., Olcese, L., Zocchi, M.R.,
objective on the Nikon PCM 2000 inverted confocal microscope; no and Rubartelli, A. (2000). Secretion of bioactive interleukin-1 by
background subtraction or other processing have been applied to dendritic cells is modulated by interaction with antigen specific T
the images. cells. Blood 95, 3809–3815.
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